Corcept Therapeutics, Inc. (CORT)
85.86
-21.64
(-20.13%)
USD |
NASDAQ |
Oct 23, 16:00
86.45
+0.59
(+0.69%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 9.266B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 9.266B |
| October 22, 2026 | 11.60B |
| October 21, 2026 | 12.55B |
| October 20, 2026 | 12.57B |
| October 19, 2026 | 12.10B |
| October 16, 2026 | 11.89B |
| October 15, 2026 | 12.24B |
| October 14, 2026 | 12.54B |
| October 13, 2026 | 12.71B |
| October 12, 2026 | 13.08B |
| October 09, 2026 | 13.08B |
| October 08, 2026 | 12.79B |
| October 07, 2026 | 12.91B |
| October 06, 2026 | 12.90B |
| October 05, 2026 | 13.17B |
| October 02, 2026 | 12.54B |
| October 01, 2026 | 12.31B |
| September 30, 2026 | 12.44B |
| September 29, 2026 | 12.38B |
| September 28, 2026 | 12.48B |
| September 25, 2026 | 12.53B |
| September 24, 2026 | 12.79B |
| September 23, 2026 | 12.19B |
| September 22, 2026 | 12.68B |
| September 21, 2026 | 12.28B |
| Date | Value |
|---|---|
| September 18, 2026 | 11.90B |
| September 17, 2026 | 12.40B |
| September 16, 2026 | 12.07B |
| September 15, 2026 | 11.96B |
| September 14, 2026 | 12.07B |
| September 11, 2026 | 12.17B |
| September 10, 2026 | 12.40B |
| September 09, 2026 | 12.49B |
| September 08, 2026 | 12.30B |
| September 04, 2026 | 12.05B |
| September 03, 2026 | 12.17B |
| September 02, 2026 | 11.92B |
| September 01, 2026 | 12.24B |
| August 31, 2026 | 12.23B |
| August 28, 2026 | 12.29B |
| August 27, 2026 | 12.62B |
| August 26, 2026 | 12.93B |
| August 25, 2026 | 13.34B |
| August 24, 2026 | 13.30B |
| August 21, 2026 | 13.19B |
| August 20, 2026 | 13.06B |
| August 19, 2026 | 12.84B |
| August 18, 2026 | 12.75B |
| August 17, 2026 | 12.65B |
| August 14, 2026 | 12.35B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.199T |
| Pfizer Inc. | 171.14B |
| Phibro Animal Health Corp. | 1.574B |
| Liquidia Corp. | 3.800B |
| Illumina, Inc. | 40.68B |
Market Cap Related Metrics
| PE Ratio | 205.06 |
| PS Ratio | 11.94 |
| Price to Book Value | 13.13 |
| Price to Free Cash Flow | 92.77 |
| Price | 85.86 |
| Earnings Yield | 0.49% |
| Operating PE Ratio | 1548.68 |
| Normalized PE Ratio | 205.06 |